Copy to clipboard 
Naitive Technologies entered into a research collaboration with Heraeus Medical and the practice Sah Orthopaedic Associates. The project will use Naitive’s flagship technology, OsteoSight, to estimate the prevalence of low bone mineral density (BMD) in patients with an AP hip or pelvic X-ray who have undergone primary elective total hip arthroplasty (THA) or total knee arthroplasty (TKA) at Sah Orthopaedic Associates. The research study will also assess the proportion of patients with low BMD, as estimated by OsteoSight, who received cementless fixation. The analysis will provide a data-driven analysis of current fixation patterns among patients with a range of bone quality.
OsteoSight, which received FDA 510(k) regulatory clearance in September 2025, analyzes routine hip and pelvic X-rays in patients 50 years and older and identifies those cases at risk for low BMD. It can be embedded into routine orthopedic clinical workflows without changing existing imaging protocols.
“With an established history in joint fixation, we’re looking to explore how bone health and fixation choices intersect in real-world settings,” said Dr. Andrew Williamson, President of Heraeus Medical. “Characterizing bone density helps us understand where cemented fixation with PALACOS technology benefits patients with compromised bone quality.”
“We’re proud to be working alongside Heraeus and Sah Orthopaedics on this project,” said Dr. Will Briggs, CEO of Naitive. “OsteoSight is redefining how we care for bone health in the orthopedic workflow. When combined with the deep clinical and surgical expertise of our partners, it creates an opportunity to better understand and ultimately improve outcomes in joint replacement.”
Naitive Technologies entered into a research collaboration with Heraeus Medical and the practice Sah Orthopaedic Associates. The project will use Naitive’s flagship technology, OsteoSight, to estimate the prevalence of low bone mineral density (BMD) in patients with an AP hip or pelvic X-ray who have undergone primary elective total hip...
Naitive Technologies entered into a research collaboration with Heraeus Medical and the practice Sah Orthopaedic Associates. The project will use Naitive’s flagship technology, OsteoSight, to estimate the prevalence of low bone mineral density (BMD) in patients with an AP hip or pelvic X-ray who have undergone primary elective total hip arthroplasty (THA) or total knee arthroplasty (TKA) at Sah Orthopaedic Associates. The research study will also assess the proportion of patients with low BMD, as estimated by OsteoSight, who received cementless fixation. The analysis will provide a data-driven analysis of current fixation patterns among patients with a range of bone quality.
OsteoSight, which received FDA 510(k) regulatory clearance in September 2025, analyzes routine hip and pelvic X-rays in patients 50 years and older and identifies those cases at risk for low BMD. It can be embedded into routine orthopedic clinical workflows without changing existing imaging protocols.
“With an established history in joint fixation, we’re looking to explore how bone health and fixation choices intersect in real-world settings,” said Dr. Andrew Williamson, President of Heraeus Medical. “Characterizing bone density helps us understand where cemented fixation with PALACOS technology benefits patients with compromised bone quality.”
“We’re proud to be working alongside Heraeus and Sah Orthopaedics on this project,” said Dr. Will Briggs, CEO of Naitive. “OsteoSight is redefining how we care for bone health in the orthopedic workflow. When combined with the deep clinical and surgical expertise of our partners, it creates an opportunity to better understand and ultimately improve outcomes in joint replacement.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
